Table 2.
Sample | µg Ga/mg GP | % HIV inhibition ± SD | |
---|---|---|---|
Day −1 dose | Days −1, 1, 3 doses | ||
GP | 0 | 10 ± 9 | 19 ± 16 |
GP-Ga2(CO3)3 | 108 | 45 ± 2a | 74 ± 17a |
GP-Ga2(CO3)3 | 150 | 53 ± 19 | 92 ± 3a |
GP-Ga2(CO3)3 | 355 | 44 ± 19 | 91 ± 2a,b |
Sample | µg Ga/mg GP | % HIV inhibition ± SD | |
---|---|---|---|
Day −1 dose | Days −1, 1, 3 doses | ||
GP | 0 | 10 ± 9 | 19 ± 16 |
GP-Ga2(CO3)3 | 108 | 45 ± 2a | 74 ± 17a |
GP-Ga2(CO3)3 | 150 | 53 ± 19 | 92 ± 3a |
GP-Ga2(CO3)3 | 355 | 44 ± 19 | 91 ± 2a,b |